Emergence of related nontoxigenic Corynebacterium diphtheriae biotype mitis strains in Western Europe. by Funke, G. et al.
477 Vol. 5, No. 3, MayJune 1999 Emerging Infectious Diseases
Dispatches
Nontoxigenic  Corynebacterium diphtheriae
strains were recovered from approximately 1 per
1,000 throat swabs from immunized British
military personnel in Germany from 1993 to
1995 (1). Such nontoxigenic C. diphtheriae
biotype  mitis  isolates had been described in skin,
throat, and blood cultures of Swiss injecting drug
users; 32 of the isolates belonged to the same
clone (2,3). Our study demonstrates that this
clone and closely related clones occurred
between 1990 and 1997 in two other European
countries, and only sometimes in persons with
poor hygiene.
Five C. diphtheriae isolates came from two
laboratories in Zurich and Bern, Switzerland; 11
from four laboratories in Hamburg, Germany;
and 1 from Paris, France (Table). They were
identified in Zurich as C. diphtheriae biotype
mitis (4); that is, they were nonlipophilic, were
nitrate reductase-positive, and did not ferment
glycogen. By polymerase chain reaction tech-
niques (5), the diphtheria toxin gene was not
detected in any isolate. For some isolates, the
Elek test was also performed; it was consistently
negative. For ribotyping, DNA was isolated,
digested with either EcoRI or PvuII, electro-
phoresed, blotted, and probed for rDNA as
described elsewhere (2,3). Disk susceptibility
testing to tetracycline and MIC determinations
were done according to National Committee for
Clinical Laboratory Standards methods (6). All
other bacteria isolated were also identified and
serotyped in Zurich.
Many (10 [59%] of 17) C. diphtheriae isolates
were from skin or subcutaneous infections
(wounds, ulcers) in Swiss patients and were
found with Staphylococcus aureus, Streptococ-
cus pyogenes, group C/G streptococci, or
(sometimes) with gram-negative rods. Most
patients in this subgroup were injecting drug
users, homeless persons, prisoners, and (with
one exception) men with a mean age of 40 (30 to
58) years. Another subgroup (from Germany)
consisted of six patients with joint or bone
infections (mentioned briefly in an earlier
publication on coryneform bacteria from such
infections; a seventh patient had C. diphtheriae
biotype gravis [7]). The six had been hospitalized
at the Endo Clinic in Hamburg, which specializes
in orthopedic surgery. Four had had im-
plantations of hip endoprostheses and had been
admitted for prosthetic infections (with coagu-
lase-negative staphylococci or S. aureus); one
pure culture of C. diphtheriae biotype mitis was
obtained from a patient with a knee prosthesis,
and one mixed culture with Peptostreptococcus
magnus  and  Peptostreptococcus prevotii was
obtained from a patient who had a purulent knee
infection after a fracture. Their average age was
60 (23 to 82) years and, to our knowledge, none
was a drug user. While the Hamburg isolates
were recovered only once from every patient,
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We report on 17 isolates of Corynebacterium diphtheriae biotype mitis with related
ribotypes from Switzerland, Germany, and France. Isolates came from skin and
subcutaneous infections of injecting drug users, homeless persons, prisoners, and
elderly orthopedic patients with joint prostheses or primary joint infections. Such isolates
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Table. Nontoxigenic Corynebacterium diphtheriae isolates
Ribotyping Patients
Isolate  Date    Place of patternc sex, Clinical diagnosis/ Other bacteria Underlying
no. isolateda   isolationb EcoRI PvuII age (yr) source isolated conditions
2012 1990 Paris A C m, 6 Endocarditis/blood               ---- Skin lesions,
  culture   scabies
2410 2/1995 Hamburg A B m, 30 Ulcus/lower leg Staphylococcus aureus, Prisoner
Streptococcus pyogenes
2689 3/1995 Hamburg A A f, 82 Puncture/hip joint S. epidermidis, Total hip joint
Corynebacterium   endoprosthesis
  pseudodiphtheriticum
1682 9/1995 Hamburg A B m, 45 Wound swab S. aureus, S. pyogenes Homelessness
1935 3/1996 Hamburg A B m, 58 Wound swab S. aureus, S. pyogenes Alcoholism,
  homelessness
1836 3/1996 Hamburg A B m, 45 Abscess/lower leg S. aureus, S. pyogenes Injecting
  drug use
2661 3/1996 Hamburg A A m, 35 Arthroscopy Peptostreptococcus Osteosynthesis,
  aspirate/knee joint   prevotii,   arthrotomy,
P. magnus   knee joint after
  trauma
2658 4/1996 Hamburg A A f, 76 Fistula/hip joint S. aureus Total hip joint
  endoprosthesis
2674 5/1996 Hamburg A A f, 62 Aspirate/hip joint Streptococcus group C Total hip joint
  endoprosthesis
2670 7/1996 Hamburg A A f, 81 Aspirate/knee joint              ---- Total knee joint
  endoprosthesis
2667 7/1996 Hamburg A A m, 23 Swab/hip joint Coagulase-negative Total hip joint
  staphylococci   endoprosthesis
2413 11/1996 Hamburg A B m, 36 Ulcus/lower leg S. aureus, Strepto- Prisoner
  coccus group C/G
2446 12/1996 Zurich A A f, 38 Wound/upper leg S. aureus, S. pyogenes Injecting drug use
2464 1/1997 Zurich A A m, 39 Ulcera/lower arm Escherichia coli, Injecting drug use
  S. aureus, S. pyogenes
2473 1/1997 Zurich A A m, 38 Ulcera/leg E. coli, Strepto- Injecting drug use
  coccus group C, G
2475 1/1997 Zurich A A m, 31 Ulcus/pretibial Pseudomonas aeru- Injecting drug use
   ginosa, E. coli, Strep-
  tococcus group C, G
480 5/1997 Bern A A m, 39 Ulcus/upper leg S. aureus, Injecting drug use
  Clostridium perfringens,
  mixed anaerobic flora
aMonth/Year
bParis, France; Hamburg, Germany;  Zurich, Switzerland;  Bern, Switzerland.
cDNA was isolated, digested with either EcoRI or PvuII, electrophoresed, blotted, and probed for DNA. Three distinct
ribopatterns emerged, each with eight bands: patterns A, B, and C.
their isolation dates stretched from March 1,
1995, until July 26, 1996. Three were isolated on
the day of admission, and all of them were
isolated by different technologists. Finally, one
child (from France) had endocarditis with
C. diphtheriae biotype mitis.
All isolates had identical antimicrobial
susceptibility patterns. They were susceptible to
amoxicillin (MIC, 0.25 µg/ml), amoxicillin-
clavulanic acid (0.06  µg/ml), chloramphenicol
(2  µg/ml), ciprofloxacin (0.25 µg/ml), clarithro-
mycin (0.03 µg/ml), clindamycin (0.25 µg/ml),
imipenem (0.03 µg/ml), penicillin (0.25 µg/ml),
and vancomycin (1 µg/ml). In contrast, all strains
were resistant to tetracycline in the disk
diffusion test (inhibition zone diameter 10 mm to
11 mm); their MICs for tetracycline, doxycycline,
and minocycline were 64  µg/ml, 16  µg/ml, and
16  µg/ml, respectively. While this type of
isolated tetracycline resistance was typical for
the isolates from Swiss injecting drug users (3),
tetracycline resistance in nontoxigenic
C. diphtheriae has otherwise very rarely been
observed in Europe (8). It has, however, been
reported in toxigenic C. diphtheriae isolates from
Indonesia and, rarely, from Canada (9). The479 Vol. 5, No. 3, MayJune 1999 Emerging Infectious Diseases
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Figure. Ribosomal RNA gene restriction patterns
obtained by using restriction enzyme Pvu II of
Corynebacterium diphtheriae isolates belonging to
ribotypes B (lanes 1 to 3), A (lanes 4 to 6 and 8), and
C (lane 7).
mechanism conferring this resistance in our
strains has not been investigated.
On analysis with restriction enzyme Pvu II,
three different ribopatterns with eight bands
each were found among the strains (Figure).
These patterns, though distinct, shared five
(A vs. C, B vs. C) and six (B vs. A) bands,
respectively, and, therefore, may be considered
related, as they would be if criteria for pulsed-
field gel electrophoresis were applied (10). This
view is supported by the fact that all strains had
identical EcoRI patterns (not shown). All Swiss
isolates were identical with the use of both
enzymes, whereas both the Swiss pattern and a
second pattern were found among the Hamburg
isolates. The third pattern was found exclusively
in the single French strain. The staphylococcal
and streptococcal strains were not typed; they
are no longer available to us.
Our isolates thus resemble those reported
from Switzerland between 1990 and early 1996
(2,3), which were also often accompanied by
S. aureus or beta-hemolytic streptococci. Such
nontoxigenic C. diphtheriae mitis may cause
endocarditis, arthritis, and osteomyelitis (11,12).
Most of the 52 isolates from France (11),
examined with restriction enzymes different
from ours and not available to us, also belonged
to one ribotype. Their relatedness to our strains
is unknown; however, they were largely
tetracycline-susceptible. The two throat isolates
from St. Petersburg, Russia, associated with a
fatal diphtherialike disease (12) were not typed
or tested for antibiotic susceptibility.
The origin of the isolates we describe is
unknown. They may have been present (but
unrecognized) in the population for a long time.
The mode of transmission is most likely common
use of drug paraphernalia in the injecting drug
use cases and in the endocarditis case;
transmission is very difficult to explain in the
orthopedic infection subgroup. Although the
Swiss and the Danish borders are not close,
migration and contacts are not uncommon
among injecting drug users. The isolates may
also have been distributed through the drugs
themselves, as recently reported for S. pyogenes
in Switzerland (13).
Our study may be representative for
Switzerland and Germany, but since submitting
C. diphtheriae strains to a central reference
laboratory in these countries is not mandatory,
we cannot estimate the frequency of these
strains. These strains may also have spread to
other European countries; this hypothesis can
only be tested in a large multicenter study of
European diphtheria reference laboratories.
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